X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-07-23 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.09 | +8,788 | 15,382,605 | 0% | +$9,579 | ||||||
2024-07-22 | NARI | Inari Medical, Inc. | Hykes Andrew | Pres, CEO | S - Sale | $55.23 | -3,000 | 460,902 | -1% | -$165,690 | ||||||
2024-07-18 | STIM | Neuronetics, Inc. | Sullivan Keith J | Pres, CEO | S - Sale | $1.90 | -24,162 | 1,324,354 | -2% | -$45,908 | ||||||
2024-07-17 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale | $202.52 | -15,000 | 932,582 | -2% | -$3,037,744 | ||||||
| M | 2024-07-17 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.13 | +12,710 | 15,373,817 | 0% | +$14,352 | |||||
2024-07-16 | LMAT | Lemaitre Vascular Inc | Lemaitre George W | COB, CEO | S - Sale | $86.69 | -57,372 | 1,900,956 | -3% | -$4,973,791 | ||||||
| M | 2024-07-16 | STIM | Neuronetics, Inc. | Sullivan Keith J | Pres, CEO | S - Sale | $1.94 | -23,762 | 1,348,516 | -2% | -$46,087 | |||||
2024-07-16 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $56.74 | -60,000 | 743,296 | -7% | -$3,404,646 | ||||||
2024-07-16 | NARI | Inari Medical, Inc. | Tu Thomas | Chief Medical Officer | S - Sale | $55.16 | -3,480 | 309,777 | -1% | -$191,957 | ||||||
2024-07-15 | SSKN | Strata Skin Sciences, Inc. | Geiger Uri | Dir, 10% | P - Purchase | $3.14 | +230,573 | 1,441,835 | +19% | +$723,999 | ||||||
2024-07-15 | SSKN | Strata Skin Sciences, Inc. | Accelmed Partners, L.P. | 10% | P - Purchase | $3.14 | +230,573 | 5,767,340 | +4% | +$723,999 | ||||||
2024-07-15 | SSKN | Strata Skin Sciences, Inc. | Rafaeli Dolev | CEO | P - Purchase | $3.14 | +19,100 | 143,156 | +15% | +$59,974 | ||||||
2024-07-15 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.14 | +91 | 15,361,107 | 0% | +$104 | ||||||
| A | 2022-05-10 | SRTS | Sensus Healthcare, Inc. | McCall William H | Dir | S - Sale | $7.54 | -10,000 | 335,723 | -3% | -$75,400 | |||||
2024-07-15 | NARI | Inari Medical, Inc. | Tu Thomas | Chief Medical Officer | S - Sale | $55.09 | -16,520 | 313,257 | -5% | -$910,087 | ||||||
| D | 2024-07-12 | NARI | Inari Medical, Inc. | Hill, Mitch C. | CFO | S - Sale+OE | $53.95 | -5,000 | 180,827 | -3% | -$269,759 | |||||
| M | 2024-07-12 | LMAT | Lemaitre Vascular Inc | Lemaitre George W | COB, CEO | S - Sale | $86.21 | -40,006 | 1,958,328 | -2% | -$3,448,752 | |||||
| M | 2024-07-11 | HAE | Haemonetics Corp | Lingamneni Anila | EVP, CTO | S - Sale | $90.00 | -2,215 | 21,331 | -9% | -$199,350 | |||||
2024-07-11 | GMED | Globus Medical Inc | Norwalk Leslie V | Dir | S - Sale | $70.00 | -1,000 | 16,419 | -6% | -$70,000 | ||||||
| D | 2024-07-08 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $192.97 | -14,683 | 444,889 | -3% | -$2,833,330 | |||||
2024-07-08 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $194.35 | -1,000 | 90,056 | -1% | -$194,350 | ||||||
| D | 2024-07-05 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $121.39 | -2,250 | 101,845 | -2% | -$273,128 | |||||
2024-07-08 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.12 | +8,411 | 15,361,016 | 0% | +$9,420 | ||||||
2024-07-05 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.14 | +8,788 | 15,352,605 | 0% | +$10,018 | ||||||
2024-07-03 | SILK | Silk Road Medical Inc | Davis Andrew S. | Chief Commercial Officer | S - Sale | $27.00 | -66 | 289,707 | 0% | -$1,782 | ||||||
| M | 2024-07-02 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $12.95 | -4,229 | 242,709 | -2% | -$54,762 | |||||
2024-07-02 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $12.90 | -3,309 | 201,180 | -2% | -$42,694 | ||||||
2024-07-01 | PEN | Penumbra Inc | Kassing Don W. | Dir | S - Sale | $179.99 | -170 | 9,505 | -2% | -$30,598 | ||||||
2024-07-01 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $179.20 | -600 | 62,288 | -1% | -$107,519 | ||||||
2024-07-02 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $6.21 | -5,055 | 163,565 | -3% | -$31,402 | ||||||
2024-07-01 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $6.42 | -3,128 | 1,759,648 | 0% | -$20,072 | ||||||
2024-07-01 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO | S - Sale | $6.42 | -12,569 | 5,738,160 | 0% | -$80,655 | ||||||
2024-07-02 | SGHT | Sight Sciences, Inc. | Park Sam Boong | COO | S - Sale | $6.21 | -3,525 | 258,229 | -1% | -$21,897 | ||||||
2024-07-02 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | CFO | S - Sale | $6.21 | -10,497 | 402,685 | -3% | -$65,207 | ||||||
2024-07-02 | IRTC | Irhythm Technologies, Inc. | Turakhia Minang | EVP, CMO, CSO | S - Sale | $105.65 | -1,404 | 27,255 | -5% | -$148,333 | ||||||
2024-07-01 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $50.15 | -20,000 | 803,296 | -2% | -$1,003,000 | ||||||
2024-07-01 | NARI | Inari Medical, Inc. | Hykes Andrew | Pres, CEO | S - Sale | $50.08 | -3,000 | 463,902 | -1% | -$150,240 | ||||||
| M | 2024-06-28 | TELA | Tela Bio, Inc. | Orbimed Advisors LLC | 10% | S - Sale | $4.72 | -428,300 | 2,407,242 | -15% | -$2,022,000 | |||||
| D | 2024-07-01 | BSX | Boston Scientific Corp | Carruthers Wendy | EVP, HR | S - Sale+OE | $77.30 | -6,983 | 42,908 | -14% | -$539,786 | |||||
2024-06-21 | HRGN | Harvard Apparatus Regenerative Technology, Inc. | He Junli | CEO | P - Purchase | $2.80 | +1,600 | 254,600 | +1% | +$4,480 | ||||||
| D | 2024-06-28 | MMSI | Merit Medical Systems Inc | Millner F. Ann | Dir | S - Sale+OE | $85.00 | -12,500 | 32,391 | -28% | -$1,062,500 | |||||
2024-06-28 | DXCM | Dexcom Inc | Brown Michael Jon | EVP GC | S - Sale | $114.29 | -659 | 66,901 | -1% | -$75,317 | ||||||
2024-06-24 | PDEX | Pro Dex Inc | Domingo Angelita Rebamontan | Dir | S - Sale | $18.30 | -2,585 | 8,191 | -24% | -$47,295 | ||||||
2024-06-24 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $6.16 | -1,184 | 300,019 | 0% | -$7,293 | ||||||
| M | 2024-06-24 | SSII | Ss Innovations International, Inc. | Cohen Barry F | COO - Americas | P - Purchase | $3.41 | +1,353 | 8,958,783 | 0% | +$4,608 | |||||
2024-06-25 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $6.95 | +1,000 | 902,140 | 0% | +$6,950 | ||||||
2024-06-21 | BVS | Bioventus Inc. | Singleton Mark Leonard | SVP, CFO | S - Sale | $5.57 | -9,219 | 84,895 | -10% | -$51,350 | ||||||
2024-06-21 | BVS | Bioventus Inc. | D'Adamio Anthony | SVP, GC | S - Sale | $5.57 | -5,904 | 95,576 | -6% | -$32,885 | ||||||
2024-06-21 | BVS | Bioventus Inc. | Church Katrina J | SVP, Chief Compliance Officer | S - Sale | $5.57 | -2,559 | 41,199 | -6% | -$14,254 | ||||||
| M | 2024-06-21 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.12 | +16,222 | 15,443,817 | 0% | +$18,094 | |||||
2024-06-21 | NARI | Inari Medical, Inc. | Chambers Rebecca | Dir | S - Sale | $45.99 | -260 | 9,684 | -3% | -$11,957 | ||||||
2024-06-17 | BVS | Bioventus Inc. | Singleton Mark Leonard | SVP, CFO | S - Sale | $5.84 | -13,753 | 63,114 | -18% | -$80,318 | ||||||
2024-06-17 | BVS | Bioventus Inc. | D'Adamio Anthony | SVP, GC | S - Sale | $5.84 | -11,308 | 81,630 | -12% | -$66,039 | ||||||
2024-06-17 | BVS | Bioventus Inc. | Church Katrina J | SVP, Chief Compliance Officer | S - Sale | $5.84 | -8,759 | 35,158 | -20% | -$51,153 | ||||||
| M | 2024-06-17 | DXCM | Dexcom Inc | Foletta Mark G | Dir | S - Sale | $117.01 | -6,000 | 59,371 | -9% | -$702,029 | |||||
2024-06-17 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $43.54 | -40,000 | 825,359 | -5% | -$1,741,579 | ||||||
2024-06-18 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.12 | +68 | 15,427,595 | 0% | +$76 | ||||||
| A | 2024-06-13 | FOMI | Formation Minerals, Inc. | Cox Scott | Pres, CEO, CFO | P - Purchase | $0.06 | +400 | 128,600 | 0% | +$24 | |||||
2024-06-14 | FOMI | Formation Minerals, Inc. | Cox Scott | Pres, CEO, CFO | P - Purchase | $0.07 | +100 | 128,500 | 0% | +$7 | ||||||
2024-06-14 | DXCM | Dexcom Inc | Heller Bridgette P | Dir | S - Sale | $113.55 | -1,000 | 25,349 | -4% | -$113,550 | ||||||
2024-06-17 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale | $62.18 | -10,000 | 52,472 | -16% | -$621,764 | ||||||
| M | 2024-06-14 | SSII | Ss Innovations International, Inc. | Cohen Barry F | COO - Americas | P - Purchase | $4.06 | +575 | 8,957,430 | 0% | +$2,336 | |||||
2024-06-17 | CATX | Perspective Therapeutics, Inc. | Hunt Jonathan Robert | CFO | P - Purchase | $9.82 | +1,800 | 35,971 | +5% | +$17,667 | ||||||
2024-06-14 | CATX | Perspective Therapeutics, Inc. | Woods Lori A | Dir | P - Purchase | $10.90 | +4,587 | 164,792 | +3% | +$49,990 | ||||||
2024-06-14 | PODD | Insulet Corp | Field Mark N | SVP, CTO | S - Sale | $199.96 | -1,500 | 12,875 | -10% | -$299,940 | ||||||
| D | 2024-06-12 | NARI | Inari Medical, Inc. | Hill, Mitch C. | CFO | S - Sale+OE | $47.60 | -5,000 | 182,894 | -3% | -$237,977 | |||||
2024-06-12 | ATEC | Alphatec Holdings, Inc. | Marshall Tyson Eliot | GC, CORP. SEC. | S - Sale | $10.88 | -50,232 | 245,638 | -17% | -$546,524 | ||||||
2024-06-12 | CTCX | Carmell Corp | Upton Richard A | Dir | P - Purchase | $2.20 | +2,000 | 54,445 | +4% | +$4,409 | ||||||
2024-06-13 | FOMI | Formation Minerals, Inc. | Cox Scott | Pres, CEO, CFO | P - Purchase | $0.06 | +400 | 121,943 | 0% | +$24 | ||||||
2024-06-13 | CATX | Perspective Therapeutics, Inc. | Spoor Johan M. | CEO | P - Purchase | $1.17 | +100,000 | 207,572 | +93% | +$117,430 | ||||||
2024-06-12 | WST | West Pharmaceutical Services Inc | Abraham Silji | SVP, CTO | S - Sale | $330.78 | -1,800 | 2,860 | -39% | -$595,404 | ||||||
2024-06-10 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $12.99 | -341 | 121,843 | 0% | -$4,430 | ||||||
| D | 2024-06-10 | PRCT | Procept Biorobotics Corp | Shiblaq Hisham | EVP, Chief Comm. Officer | S - Sale+OE | $68.24 | -26,046 | 55,860 | -32% | -$1,777,499 | |||||
| DM | 2024-06-07 | VERO | Venus Concept Inc. | Masters Michael Willingham | 10% | S - Sale+OE | $1.20 | -489,948 | 1,050,047 | -32% | -$589,868 | |||||
| D | 2024-06-10 | MMSI | Merit Medical Systems Inc | Peterson Neil | COO | S - Sale+OE | $81.85 | -7,500 | 14,819 | -34% | -$613,845 | |||||
2024-06-10 | CTCX | Carmell Corp | Cassaday Bryan J. | CFO | P - Purchase | $2.50 | +440 | 2,775 | +19% | +$1,100 | ||||||
2024-06-10 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP CFO | S - Sale | $115.05 | -745 | 84,948 | -1% | -$85,713 | ||||||
2024-06-10 | DXCM | Dexcom Inc | Stern Sadie | EVP CHRO | S - Sale | $115.05 | -427 | 75,877 | -1% | -$49,127 | ||||||
2024-06-10 | DXCM | Dexcom Inc | Leach Jacob Steven | EVP COO | S - Sale | $115.05 | -745 | 312,873 | 0% | -$85,713 | ||||||
2024-06-11 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $5.88 | +45,000 | 11,712,224 | 0% | +$264,600 | ||||||
2024-06-10 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $209.81 | -1,000 | 91,056 | -1% | -$209,810 | ||||||
2024-06-10 | PODD | Insulet Corp | Scannell Timothy J | Dir | S - Sale | $190.51 | -7,000 | 35,586 | -16% | -$1,333,570 | ||||||
2024-06-10 | PODD | Insulet Corp | Field Mark N | SVP, CTO | S - Sale | $190.43 | -2,131 | 14,375 | -13% | -$405,806 | ||||||
2024-06-06 | NMTC | Neuroone Medical Technologies Corp | Christianson Mark | Business Development Dir | S - Sale | $0.88 | -2,189 | 295,035 | -1% | -$1,918 | ||||||
2024-06-10 | BDX | Becton Dickinson & Co | Spoerel Thomas J | SVP,Controller, Chief Acct Off | S - Sale | $239.31 | -300 | 2,093 | -13% | -$71,793 | ||||||
| D | 2024-06-07 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $211.66 | -14,683 | 444,889 | -3% | -$3,107,739 | |||||
| M | 2024-05-28 | CTCX | Carmell Corp | Shukla Rajiv | COB, CEO, 10% | P - Purchase | $2.57 | +4,120 | 4,322,011 | 0% | +$10,578 | |||||
2024-06-05 | NMTC | Neuroone Medical Technologies Corp | Christianson Mark | Business Development Dir | S - Sale | $0.88 | -25,800 | 297,224 | -8% | -$22,663 | ||||||
| D | 2024-06-04 | NVCR | Novocure Ltd | Vernon W Anthony | Dir | S - Sale+OE | $23.89 | -964 | 334,683 | 0% | -$23,033 | |||||
| D | 2024-06-04 | NVCR | Novocure Ltd | Scannell Timothy J | Dir | S - Sale+OE | $23.89 | -964 | 10,945 | -8% | -$23,027 | |||||
| D | 2024-06-04 | NVCR | Novocure Ltd | Leung Gabriel | Dir | S - Sale+OE | $23.89 | -964 | 161,367 | -1% | -$23,025 | |||||
2024-06-06 | STIM | Neuronetics, Inc. | Cascella Robert | Dir | P - Purchase | $2.05 | +50,000 | 244,098 | +26% | +$102,550 | ||||||
2023-12-01 | ARAY | Accuray Inc | Chalke Sandeep | SVP, Chief Commercial Officer | S - Sale | $1.70 | -26,799 | 531,341 | -5% | -$45,612 | ||||||
2024-06-04 | ARAY | Accuray Inc | Pervaiz Ali | SVP CFO | S - Sale | $1.70 | -2,701 | 402,542 | -1% | -$4,597 | ||||||
| D | 2024-06-03 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $113.50 | -2,500 | 101,845 | -2% | -$283,751 | |||||
2024-06-03 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $188.90 | -600 | 62,888 | -1% | -$113,339 | ||||||
2024-06-03 | LUNG | Pulmonx Corp | Lehman David Aaron | GC | S - Sale | $6.97 | -5,475 | 209,113 | -3% | -$38,161 | ||||||
2024-06-03 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $6.97 | -4,297 | 301,203 | -1% | -$29,950 | ||||||
2024-06-04 | PODD | Insulet Corp | Borio Luciana | Dir | S - Sale | $182.58 | -360 | 3,298 | -10% | -$65,729 | ||||||
2024-06-03 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.02 | +6,144 | 15,427,527 | 0% | +$6,267 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |